Back to Authors

Zhou, Ming‐Ming

https://orcid.org/0000-0002-7049-0573

Mayo Clinic

Icahn School of Medicine at Mount Sinai

Citations 1

The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor
Marango, Jotin, Nishio, Hitomi, Meyer, Julia A., Sirulnik, Andres, Martinez-Martinez, Yolanda, Chesi, Marta , Bergsagel, P. Leif , Zhou, Ming‐Ming , Waxman, Samuel, Leibovitch, Boris A. , Walsh, Martin J. , Licht, Jonathan D. , Shimoyama, Manabu , Min, Dong Joon , Bergsagel, P. Leif

Blood | December 22, 2007 | Volume: 111 | Issue: 6 | Pages: 3145-3154

10.1182/blood-2007-06-092122 Get It

Abstract MMSET, identified by its fusion to the IgH locus in t(4;14)-associated multiple myeloma, possesses domains found within chromatin regulators, including the SET domain. MMSET protein is overexpressed and highly associated with chromatin in myeloma cell lines carrying t(4;14). MMSET possesses methyltransferase activity for core histone H3 lysine 4 and histone 4 lysine 20, whereas MMSET made in cells only modified H4. Segments of MMSET fused to the Gal4 DNA binding domain repressed transcription of a chromatin-embedded Gal4 reporter gene. MMSET-mediated repression was associated with increased H4K20 methylation gene and loss of histone acetylation. Consistent with this repressive activity, MMSET could form a complex with HDAC1 and HDAC2, mSin3a, and the histone demethylase LSD1, suggesting that it is a component of corepressor complexes. Furthermore, MMSET coexpression enhances HDAC1- and HDAC2-mediated repression in transcriptional reporter assays. Finally, shRNA-mediated knockdown of MMSET compromised viability of a myeloma cell line, suggesting a biologic role for the protein in malignant cell growth. Collectively, these data suggest that, by acting directly as a modifier of chromatin as well as through binding of other chromatin-modifying enzymes, MMSET influences gene expression and potentially acts as a pathogenic agent in multiple myeloma.